Babak Rad, MD
Colon & Rectal Surgery · Newport Beach, CANPI 1821013046
Payments from drug & device makers
Across 45 payments — averaging $143.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Davol Inc.$79
- Bard Access Systems, Inc.$76
- Braintree Laboratories, Inc.$67
- Covidien LP$40
- Vioptix Inc$25
- plus $96 from 5 others
What the payments were for
- Speaking & faculty fees$2,65041%
- Travel & lodging$1,67726%
- Food & beverage$1,13918%
- Education$1,00015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 30 | $6,085 |
| Davol Inc. | 2 | $79 |
| Bard Access Systems, Inc. | 1 | $76 |
| Braintree Laboratories, Inc. | 5 | $67 |
| Covidien LP | 1 | $40 |
| Vioptix Inc | 1 | $25 |
| NEW World Medical,inc. | 1 | $24 |
| AbbVie | 1 | $21 |
| Shire North American Group Inc | 1 | $19 |
| Sanofi | 1 | $19 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,441
How this compares
$6,466 in reported general payments places this provider in the 60th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 117 | $7,590 |
| Hydrocortisone | 56 | $1,397 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 35 | $441 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 16 | $377 |
| Procto-Med HcHydrocortisone | 14 | $238 |
| Neomycin Sulfate | 34 | $237 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 13 | $206 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $191 |
| Metronidazole | 35 | $97 |
| Ondansetron OdtOndansetron | 23 | $71 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $67 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Newport Beach
- Daniel NgNewport Beach$10K
- Sang LeeLos Angeles$2.6M
- Pamela LeeSan Diego$544K
- Phillip FleshnerWest Hollywood$404K
- Hueylan ChernSan Francisco$328K
- Joseph CarmichaelOrange$179K
- Samuel EisensteinSan Diego$147K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.